logging in or signing up accelerated stability study ppt aSGuest117577 Download Post to : URL : Related Presentations : Let's Connect Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Copy embed code: Embed: Flash iPad Dynamic Copy Does not support media & animations Automatically changes to Flash or non-Flash embed WordPress Embed Customize Embed URL: Copy Thumbnail: Copy The presentation is successfully added In Your Favorites. Views: 2936 Category: Education License: All Rights Reserved Like it (0) Dislike it (0) Added: October 21, 2011 This Presentation is Public Favorites: 2 Presentation Description No description available. Comments Posting comment... By: sasi_90 (30 month(s) ago) nice ppt. Saving..... Post Reply Close Saving..... Edit Comment Close Premium member Presentation Transcript ACCELERATED STABILITY STUDY: ACCELERATED STABILITY STUDY Presented by: Swati D. Shirke (M.Pharm SEM-I ) Department of Pharmaceutics Supervised by : Dr . J. I. Disouza (Principal) Department of Pharmaceutics Guided by : Mr. S. A. Payghan (H.O.D ) Department of Pharmaceutics Tatyasaheb Kore College of Pharmacy, Warananagar 1CONTENTS: CONTENTS Introduction Activation energy Arrhenius equation Accelerated stability testing Limitations of accelerated stability testing ICH guidelines References 2INTRODUCTION: INTRODUCTION Stability: Stability of pharmaceutical product may be defined as the capability of a particular formulation in a specific container/closure system to remain within its physical, chemical, microbiological, therapeutic and toxicological specification. 3Slide 4: Need for stability testing : Provide evidence as to how the quality of the drug product varies with time. Establish shelf life for the drug product. Determine recommended storage conditions. Determine container closure system suitability. Safety point of view of patient. Prevention of economical repercussion. Essential quality attribute. 4According to USP Types of Stability: According to USP Types of Stability Type Condition to be maintained 1.Chemical : Chemical integrity & lebelled potency 2.Physical: Appearance, palatability, uniformality. 3.Microbiological Sterility 4.Therapeutic: Drug action remains unchanged 5.Toxicological: No increase in toxicity 5Slide 6: ACTIVATION ENERGY : It is defined as the energy that must be overcome in order for a chemical reaction to occur. Activation energy may also be defined as the minimum energy required to start a chemical reaction. The activation energy of a reaction is usually denoted by E a , and given in units of kilojoules per mole. 6Slide 7: ARRHENIUS EQUATION : Arrhenius equation gives "the dependence of the rate constant k of chemical reaction on the temperature T (in absolute temperature, such as Kelvin or degrees Rankine) and activation energy E a ", as shown below: Where k=specific rate constant A=frequency factor Ea= activation energy R=ideal gas constant T=absolute temperature 7 Take log on both sides, ln k = ln A –Ea/RT ln e (2) Converting eq. 2 to log 10 log k = log A – Ea/2.303RT (1)Slide 8: Estimation of k: 1.Reaction is conducted at several temp. 2.Conc. is determined at different time period. 3.Order of reaction is identified. 4.From slope of line k is calculated. 8 Fig. EstimationEstimation of activation energy:: Estimation of activation energy: A graph can be drawn by taking log k on y-axis and reciprocal temperature (1/T) on x-axis. A straight line is obtained, the slope of the line is negative and the magnitude is Ea /2.303 R. The intercept corresponds to log A. All the constants in the Arrhenius equation can be obtained from the graph. 9 Fig. estimation of activation energySlide 10: Calculation of shelf life : ORDER X axis Y axis HALF LIFE SHELF LIFE ZERO Time (a-x) a/2k 0.1A 0 /K 0 FIRST Time log(a-x) 0.693/k 0.105/K 1 SECOND ( a=b) Time 1/(a-x) 1/ka - SECOND ( a≠b ) Time Log b(a-x )/a (b-x) 1/ka - THIRD Time 1/(a-x) 2 3/2ka 2 -TYPES OF STABILITY TESTS:: TYPES OF STABILITY TESTS: Long term stability tests Field test Accelerated stability tests Accelerated stability studies: Studies designed to increase the rate of chemical degradation or physical change of an active substance or drug product by using exaggerated storage conditions as part of the formal, definitive storage programme . 11Tests at elevated temperature:: Tests at elevated temperature: Drug liquid preparation stored at 50, 60, 70,85,100 and 121˚c. Also study performed at R.T. and or refrigerator temp. Sampling: First year- 3 month interval Second year- 6 month interval Four climatic zones: Temperate zone 21˚c/45%RH Mediterranean zone 25˚c/60%RH Tropical zone 30˚c/70%RH Desert zone 30˚c/35%RH 12Tests at high intensity of light:: Tests at high intensity of light: Drug substances fade or darken on exposing to light, can be controlled by using amber glass or opaque container. By exposing drug substance to 400 & 900 (FC)of illumination for 4 & 2 weeks to light and another sample examined protected from light . Results found on appearance and chemical loss may be recorded. Comparing color or using diffused reflectance spectroscopy for examination. e.g. cycloprofen becomes very yellow after five days under 900 foot candles of light. 13Tests at high partial pressure of oxygen:: Tests at high partial pressure of oxygen: Sensitivity of the drugs to atmospheric oxygen must be evaluated from which it should be packed in inert atmospheric condition with antioxidants is decided . Here, high oxygen tension plays important role to investigate stability Usually , 40% of oxygen atmosphere allows for rapid evaluation. Results were correlated with inert & without inert condition . 14Tests at high relative humidity:: Tests at high relative humidity: Presence of moisture may cause hydrolysis and oxidation. These reactions may accelerated by exposing the drug to different relative humidities. Control humidity by Lab desiccators Closed dessicator are placed in an oven to provide constant temperature. 15LIMITATIONS OF ACCELERATED STABILITY TESTING: LIMITATIONS OF ACCELERATED STABILITY TESTING Valid only when the break down depends on temperature. The energy of activation obtained in the study should be between 10 to 30 kcal/mole. It is not useful when degradation is due to: Microbial contamination Photochemical reactions Diffusion Excessive agitation When the product looses its physical integrity at higher temperatures. When the order changes at elevated temperatures. 16STABILITY PROTOCOL:: STABILITY PROTOCOL: Containers and closures Container orientation Sampling interval Type, size and number of batches Plan of sampling Storage conditions Test methodology Acceptance criteria 17ICH GUIDELINES ON STRESS TESTING:: ICH GUIDELINES ON S TRESS TESTING : Standard Title and reference ICH Q1A(R2) Stability Testing of New Drug Substances and Products (the parent guideline ) ICH Q1B Photostability Testing of New Drug Substances and Products ICH Q C Stability testing of new dosage forms ICH D Bracketing and matrixing designs ICH Q E Evaluation of stability data ICH Q F Stability data package for registration applications in climatic zone I and IV 18REFERENCES: REFERENCES Patrick J.Sinko , Martin’s Physical Pharmacy and Pharmaceutical Sciences. Theory and practice of Industrial Pharmacy – Lachman International Stability Testing Drug stability- Cartensen C.V.S. Subrahmanyam www.ich.org 19THANK YOU…: THANK YOU… 20Slide 21: 21 You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.